rs6485702

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002334.4(LRP4):​c.3256A>G​(p.Ile1086Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.625 in 1,613,140 control chromosomes in the GnomAD database, including 326,662 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1086L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.51 ( 23301 hom., cov: 30)
Exomes 𝑓: 0.64 ( 303361 hom. )

Consequence

LRP4
NM_002334.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 2.13

Publications

58 publications found
Variant links:
Genes affected
LRP4 (HGNC:6696): (LDL receptor related protein 4) This gene encodes a member of the low-density lipoprotein receptor-related protein family. The encoded protein may be a regulator of Wnt signaling. Mutations in this gene are associated with Cenani-Lenz syndrome. [provided by RefSeq, May 2010]
LRP4 Gene-Disease associations (from GenCC):
  • Cenani-Lenz syndactyly syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • congenital myasthenic syndrome 17
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sclerosteosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sclerosteosis 2
    Inheritance: SD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.3157668E-6).
BP6
Variant 11-46877220-T-C is Benign according to our data. Variant chr11-46877220-T-C is described in ClinVar as Benign. ClinVar VariationId is 304872.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.658 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP4NM_002334.4 linkc.3256A>G p.Ile1086Val missense_variant Exon 23 of 38 ENST00000378623.6 NP_002325.2
LRP4XM_017017734.2 linkc.3256A>G p.Ile1086Val missense_variant Exon 23 of 39 XP_016873223.1
LRP4XM_011520103.3 linkc.2452A>G p.Ile818Val missense_variant Exon 17 of 32 XP_011518405.1
LRP4XM_011520104.3 linkc.1021A>G p.Ile341Val missense_variant Exon 8 of 23 XP_011518406.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP4ENST00000378623.6 linkc.3256A>G p.Ile1086Val missense_variant Exon 23 of 38 1 NM_002334.4 ENSP00000367888.1

Frequencies

GnomAD3 genomes
AF:
0.515
AC:
78201
AN:
151806
Hom.:
23290
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.208
Gnomad AMI
AF:
0.634
Gnomad AMR
AF:
0.569
Gnomad ASJ
AF:
0.734
Gnomad EAS
AF:
0.297
Gnomad SAS
AF:
0.668
Gnomad FIN
AF:
0.623
Gnomad MID
AF:
0.647
Gnomad NFE
AF:
0.663
Gnomad OTH
AF:
0.571
GnomAD2 exomes
AF:
0.586
AC:
147226
AN:
251342
AF XY:
0.605
show subpopulations
Gnomad AFR exome
AF:
0.196
Gnomad AMR exome
AF:
0.488
Gnomad ASJ exome
AF:
0.731
Gnomad EAS exome
AF:
0.284
Gnomad FIN exome
AF:
0.631
Gnomad NFE exome
AF:
0.672
Gnomad OTH exome
AF:
0.654
GnomAD4 exome
AF:
0.636
AC:
929801
AN:
1461214
Hom.:
303361
Cov.:
48
AF XY:
0.640
AC XY:
465231
AN XY:
726960
show subpopulations
African (AFR)
AF:
0.194
AC:
6491
AN:
33462
American (AMR)
AF:
0.501
AC:
22412
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.732
AC:
19123
AN:
26130
East Asian (EAS)
AF:
0.296
AC:
11765
AN:
39692
South Asian (SAS)
AF:
0.662
AC:
57095
AN:
86240
European-Finnish (FIN)
AF:
0.636
AC:
33996
AN:
53416
Middle Eastern (MID)
AF:
0.661
AC:
3811
AN:
5762
European-Non Finnish (NFE)
AF:
0.663
AC:
737256
AN:
1111432
Other (OTH)
AF:
0.627
AC:
37852
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
18761
37522
56284
75045
93806
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18818
37636
56454
75272
94090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.515
AC:
78217
AN:
151926
Hom.:
23301
Cov.:
30
AF XY:
0.515
AC XY:
38233
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.208
AC:
8609
AN:
41422
American (AMR)
AF:
0.569
AC:
8680
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.734
AC:
2545
AN:
3466
East Asian (EAS)
AF:
0.296
AC:
1522
AN:
5142
South Asian (SAS)
AF:
0.669
AC:
3220
AN:
4816
European-Finnish (FIN)
AF:
0.623
AC:
6575
AN:
10562
Middle Eastern (MID)
AF:
0.647
AC:
189
AN:
292
European-Non Finnish (NFE)
AF:
0.663
AC:
45079
AN:
67946
Other (OTH)
AF:
0.578
AC:
1221
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1628
3255
4883
6510
8138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
670
1340
2010
2680
3350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.638
Hom.:
100290
Bravo
AF:
0.494
TwinsUK
AF:
0.669
AC:
2479
ALSPAC
AF:
0.656
AC:
2528
ESP6500AA
AF:
0.222
AC:
977
ESP6500EA
AF:
0.667
AC:
5733
ExAC
AF:
0.585
AC:
70996
Asia WGS
AF:
0.530
AC:
1847
AN:
3478
EpiCase
AF:
0.678
EpiControl
AF:
0.683

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 28, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cenani-Lenz syndactyly syndrome Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19079262, 23321396) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome 17 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sclerosteosis 2 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
12
DANN
Benign
0.80
DEOGEN2
Benign
0.10
T
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.14
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.71
T
MetaRNN
Benign
0.0000013
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.20
N
PhyloP100
2.1
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.12
N
REVEL
Benign
0.22
Sift
Benign
0.81
T
Sift4G
Benign
0.55
T
Polyphen
0.0
B
Vest4
0.058
MPC
0.45
ClinPred
0.0017
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.025
gMVP
0.42
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6485702; hg19: chr11-46898771; COSMIC: COSV66134767; COSMIC: COSV66134767; API